Press Releases
Priorclave’s Cylindrical Autoclaves Improve Laboratory Performance
Priorclave's QCS front-loading autoclave range should help any laboratory increase its sterilising throughput thanks to a combination of an improved load capacity and strong operating performance. There may also be an added benefit of lower overall...
Press Releases
SHL in Korea: Insight into the Changing World of Auto Injectors
The global injectable drug delivery device technologies market was valued at approximately $10.2bn in 2012 and is expected to grow at a CAGR rate of 11% to $17.2bn by 2017. This comes as no surprise as...
Press Releases
Tissue Solutions Announces New CEO
We are pleased to announce the appointment of Dr Morag McFarlane as chief executive officer of Tissue Solutions Ltd. Morag has served for the past seven years as chief scientific officer at Tissue Solutions Ltd, and...
Press Releases
Patheon to Showcase its Complex Formulation Technologies Expertise at CPhI/ICSE – Japan Conference
The global injectable drug delivery device technologies market was valued at approximately $10.2bn in 2012 and is expected to grow at a CAGR rate of 11% to $17.2bn by 2017. This comes as no surprise as...
Press Releases
Anton Paar Releases New MCP 100 Polarimeter
The new, extremely compact MCP 100 polarimeter now helps anyone working with optically active substances to reach all required targets in a fully traceable fashion. Its high quality is a given: the instrument is launched by technology leader Anton...
Press Releases
Ferrer licenses commercialisation rights for Ozenoxacin in the United States to Medimetriks Pharmaceuticals Inc.
Ferrer, a privately-held Spanish pharmaceutical company today announces that it has licensed commercialisation rights for Ozenoxacin one per cent cream in the United States of America, Puerto Rico and the U.S. Virgin Islands to Medimetriks Pharmaceuticals Inc. Under the...
Press Releases
Provepharm¹s Japanese partner Daiichi Sankyo files an NDA to market the Methylene Blue injection medicinal product in Japan
Provepharm, a French company specialized in the development of pharmaceutical applications announces that Daiichi Sankyo, Co. Ltd., a global pharmaceutical firm, has filed an NDA For the development and marketing of the injectable Methylene Blue medicinal...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read